Today, an international group of leading scientists publish recommendations for updating existing standards for determining the disease-causing potential of genomic variants, harnessing insights from ...

Genomics England has deployed an enterprise imaging system from supplier Sectra to link radiology and pathology images with whole genome sequencing data. The implementation of the system is part of ...

The human genome is made up of 3 billion letters of DNA (A, T, C and G). Whole genome sequencing is a technique that is used ...

The UK Rare Diseases Framework, led by the Department of Health and Social Care, also helps drive collaborative progress ...

SAN JOSE, Calif., Sept. 10, 2020 /PRNewswire/ -- Quantum Corp. (NASDAQ: QMCO) today announced that Genomics England has expanded their Quantum ActiveScale object storage solution as part of an ...

Revvity (RVTY) announced an expansion of its work with Genomics England that leverages both organizations’ expertise and resources to advance critical genomic initiatives across the United Kingdom.

WALTHAM, Mass.--(BUSINESS WIRE)--Revvity, Inc. (NYSE: RVTY) today announced an agreement with Genomics England to further collaborate on the Generation Study. Under the new contract, Revvity will now ...

Job Description Key responsibilities Working collaboratively with the Participant Panel Chair and Vice-Chair for Rare Conditions: Help to shape ...

Genomics England has joined forces with public cloud giant Amazon Web Services (AWS) and biomedical data processing company Lifebit to create a Covid-19-related genomic research platform. The ...

A video has confused some social media users into thinking that Britain’s health minister personally owns a genomic research company. The clip shows Matt Hancock introducing himself as “the proud ...

SAN JOSE — Sept. 10, 2020 — Quantum Corp. (NASDAQ: QMCO) today announced that Genomics England has expanded their Quantum ActiveScale object storage solution as part of an integrated environment ...

LONDON, 19 July 2022 – Today, an international group of leading scientists publish recommendations for updating existing standards for determining the disease-causing potential of genomic variants, ...